Literature DB >> 22918041

Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.

Boris Shenkman1, Tami Livnat, Ivan Budnik, Ilia Tamarin, Yulia Einav, Uriel Martinowitz.   

Abstract

The relationship between tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA) function is not fully understood. The aim of this study was to compare in vitro the fibrinolytic activity of tPA and uPA and evaluate their possible interaction. Blood coagulation and fibrinolysis were conducted by rotation thromboelastometry, whereas blood clotting was induced by CaCl2 and tissue factor and fibrinolysis additively by tPA and uPA. Effective concentration 50% of tPA and uPA fibrinolytic activity in blood was found to be 90 and 33 IU/ml relating to the units of activity established by manufacturers in the absence of blood. uPA-induced fibrinolysis in blood was faster compared with tPA used at the same units of activity. In contrast, in a blood-free system containing fibrinogen, plasminogen, and thrombin, fibrinolysis induced by uPA was weaker than by tPA. Treating of blood with tranexamic acid (60 mmol/l) was followed by decreased fibrinolytic potential of both exogenous tPA and uPA, despite uPA by itself is known to be not sensitive to aminocaproic acids. Thus, uPA exerted stronger activity in blood but weaker activity in blood-free system, compared with tPA. Taking into account the intermolecular binding of uPA to tPA, it could be suggested that interaction of exogenous uPA with plasma-containing tPA provided amplification of fibrinolysis due to formation of uPA/tPA complex possessing high affinity to fibrin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22918041     DOI: 10.1097/MBC.0b013e32835897d5

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  3 in total

1.  Endovenous Laser Ablation of Varicose Veins Preserves Biological Properties of Vascular Endothelium and Modulates Proinflammatory Agent Profile More Favorably Than Classic Vein Stripping.

Authors:  Paweł Uruski; Krzysztof Aniukiewicz; Justyna Mikuła-Pietrasik; Patrycja Sosińska; Andrzej Tykarski; Krzysztof Książek; Zbigniew Krasiński
Journal:  Biomed Res Int       Date:  2017-02-20       Impact factor: 3.411

2.  Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity.

Authors:  Gerhardus J A J M Kuiper; Marie-Claire F Kleinegris; René van Oerle; Henri M H Spronk; Marcus D Lancé; Hugo Ten Cate; Yvonne M C Henskens
Journal:  Thromb J       Date:  2016-01-14

3.  Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease.

Authors:  Tomasz W Kaminski; Krystyna Pawlak; Malgorzata Karbowska; Michal Mysliwiec; Waldemar Grzegorzewski; Jakub Kuna; Dariusz Pawlak
Journal:  Int Urol Nephrol       Date:  2017-10-22       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.